Trial Profile
An Open-Label Study to Determine the Safety and Efficacy of Alefacept as Monotherapy in Subjects With Chronic Plaque Psoriasis Who Have Failed to Respond to Anti-TNF Therapy.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2013
Price :
$35
*
At a glance
- Drugs Alefacept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 29 Sep 2009 New trial record